39
Participants
Start Date
May 31, 2012
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
cisplatin and 5-Fu combined with nimotuzumab
"DDP+5-Fu DDP 100 mg/m2 intravenous infusion in day1, 5-Fu 1000mg/m2/d continuous intravenous infusion on days 1 through 4, both drugs are given every 3 weeks.~Nimotuzumab 200mg/d, intravenous infusion every week"
Cancer Center, Sun Yat-sen University, Guangzhou
Fujian Cancer Hospital
OTHER_GOV
First People's Hospital of Foshan
OTHER
People's Hospital of Guangxi Zhuang Autonomous Region
OTHER
Guangxi Medical University
OTHER
Guangzhou Medical University
OTHER
Hubei Cancer Hospital
OTHER
Hunan Provincial Cancer Hospital
UNKNOWN
Hangzhou Cancer Hospital
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Tongji Hospital
OTHER
Jiangxi Provincial Cancer Hospital
OTHER
Affiliated Cancer Hospital of Shantou University Medical College
OTHER
Wuhan University
OTHER
Zhejiang Cancer Hospital
OTHER
Sun Yat-sen University
OTHER